Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer
Authors
Keywords
Breast cancer, Metastasis, EMT, Migration, Sanguinarine
Journal
PHYTOMEDICINE
Volume 84, Issue -, Pages 153500
Publisher
Elsevier BV
Online
2021-02-11
DOI
10.1016/j.phymed.2021.153500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sanguinarine disrupts the colocalization and interaction of HIF‐1α with tyrosine and serine phosphorylated‐STAT3 in breast cancer
- (2020) Qi Su et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner
- (2020) Man Zhu et al. PHARMACOLOGICAL RESEARCH
- Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells
- (2020) Aveen N. Adham et al. PHYTOMEDICINE
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Breast Cancer Demographics, Types and Management Pathways: Can Western Algorithms be Optimally used in Eastern Countries?
- (2019) S. Chakraborty et al. CLINICAL ONCOLOGY
- LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
- (2019) Bingqiu Xiu et al. Molecular Cancer
- Sanguinarine inhibits epithelial–mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma
- (2019) Qi Su et al. Cell Death & Disease
- Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis
- (2018) Yaqi Lv et al. Theranostics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular targets and anticancer potential of sanguinarine—a benzophenanthridine alkaloid
- (2017) Sehamuddin Galadari et al. PHYTOMEDICINE
- Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils
- (2017) Gabriela Vazquez Rodriguez et al. Cancer Immunology Research
- In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients
- (2016) Savvas Petanidis et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells
- (2016) Sensen Lin et al. PHYTOMEDICINE
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
- (2015) Y-C Wu et al. ONCOGENE
- In vitro inhibitory effects of terpenoids from Chloranthus multistachys on epithelial–mesenchymal transition via down-regulation of Runx2 activation in human breast cancer
- (2015) Jianjiang Fu et al. PHYTOMEDICINE
- TGFβSignaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
- (2015) Panagiotis Papageorgis Journal of Oncology
- Involvement of heme oxygenase-1 in neuroprotection by sanguinarine against glutamate-triggered apoptosis in HT22 neuronal cells
- (2014) Sun Young Park et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Brucine, an effective natural compound derived from nux-vomica, induces G1 phase arrest and apoptosis in LoVo cells
- (2013) Lei Zheng et al. FOOD AND CHEMICAL TOXICOLOGY
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
- (2012) Philip H. Quanjer et al. EUROPEAN RESPIRATORY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started